Immunotherapeutic Evaluation of Cancer Vaccines

Tumor vaccines which are among the methods of immunotherapy have an important place against other treatment methods in the fight with cancer. The aim of immunotherapy is to allow the cells of the immune system to destroy cancer cells by targeting them. For this reason, commonly used immunotherapy methods include monoclonal antibodies, and in particular cancer vaccines. In comparison to other methods, cancer vaccines are more specific that activate T lymphocytes of patients and tries to strengthen the defense of the organism against cancer cells. For this reason, unlike other methods in the fight against cancer, cancer vaccination has been used as a more specific treatment. Many new and effective cancer vaccines are likely to arise with the advancement of studies. There are vaccines currently in progress between phase II and III, which are pending approval from the Food and Drug Administration (FDA). The progress of research on cancer vaccines and the availability of new FDA-approved vaccines has been a source of hope for cancer patients